Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

K
Kýlýnç M. - Thrombotic risk factors in stroke patients
Kaaja R. - Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin
  - Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy
  - Treatment of acute pulmonary embolism during pregnancy with low-molecular weight heparin
Kabile F. - Involvement of the aIIb subunit in postligand binding signaling events
Kadegasem P. - Prevalence of Arg 506 and Arg 306 mutations of the factor V gene in Thai blood donors
  - Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Kadl A. - Urokinase receptor (uPAR) regulates integrin redistribution during initial vascular endothelial growth factor (VEGF)-induced endothelial cell migration
  - Oxidized phospholipids induce the human heme oxygenase-1 via CREB: a feedback mechanism in inflammatory disorders
  - Oxidized phospholipids induce proatherogenic genes in murine carotid arteries
Kadziola Z. - Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction
  - Low-molecular weight heparin therapy and survival in patients with malignant disease
  - Phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis
Kageyama S. - A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers
Kahan J. P. - Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
Kahles T. - Lupus anticoagulant in systemic lupus erythematodes as risk factor for cryptogenic stroke
Kahn M. - Role Of SLP-76 and SYK signaling for separation of blood and lymphatic vascular networks
Kahn S. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
  - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Kahn S. R. - Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
  - Patients with the post–thrombotic syndrome have worse disease severity and quality of life than patients with primary chronic venous disease
Kahn S. R. - Activated protein C resistance in cancer-associated venous thromboembolism
  - Specific and nonspecific antiphospholipid antibodies in recurrent fetal loss: a meta-analysis
Kahnamoui K. - Prognostic value of activated protein C levels in patients with severe sepsis
Kahnamoui S. - Prognostic value of activated protein C levels in patients with severe sepsis
Kahner B. - Stimulation of PAR-1 does not lead to G protein redistribution in human platelets
Kahr W. H. A. - Platelet-dependent alterations in fibrinolysis in the Quebec platelet disorder
Kai H. - Exposure of procoagulant phospholipids in blood during exhaustive physical exercise
Kaibara M. - Purification and identification of coagulation factor IX-activating enzyme on the erythrocyte membranes
Kaibara M. - Activation of factor IX by erythrocyte membranes is a trigger for coagulation at stasis
Kaider A. - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Kain K. - Increased coagulation factor XIII B subunit antigen and factor XIII biotin activity is associated with family history of stroke in South Asians
  - Increased factor XIII B and decreased factor XIII A subunit antigen levels in insulin resistant South Asian patients with ischaemic stroke
Kaiser P. - Reviparin normalizes tissue factor pathway activation in patients with lower limb immobilization and is not associated with heparin antibody production
Kaiser P. - Lower limb trauma is associated with a moderate risk of thrombosis caused by sustained release of tissue factor despite early functional mobilization
Kakela J. K. - A case of compound type 2N/type 1 von Willebrand disease linked to a novel von Willebrand factor exon 18 mutation A2311G encoding for Met 771 val
Kakkar V. V. - High affinity heparin binding proteins are exposed on the surface and microvesicles of TF bearing cells and diminish heparin-mediated anticoagulation
Kakkar A. - Does LMWH improve long-term survival in patients with cancer?
Kakkar A. K. - Anti-angiogenic activity of heparins and anti-thrombin
Kakkar V. - The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Kakkar A. K. - Prophylaxis against venous thromboembolism
Kakkar A. - Foundations of clinical practice - Thromboprophylaxis
Kakkar V. V. - Phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis
  - Evidence supporting a functional role for the metal binding site observed within the protease domain of Factor IXa
Kakkar A. - Venous thrombosis in cancer patients: insights from the FRONTLINE survey
  - Low-molecular weight heparin therapy and survival in patients with malignant disease
Kakkar A. K. - From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer
Kakkar V. V. - Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction
  - Platelet factor 4 (PF4) neutralizes heparan sulfate-dependent inactivation of factor Xa by preventing enzyme interaction with polysaccharide
  - Control of Factor Xa activity by heparin in plasma is related to the inhibition of free Factor Xa
Kakkar A. K. - Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement
  - Blood transfusion is associated with an enhanced pro angiogenic state
Kakkar V. V. - Identification of individuals at high risk of developing Ischaemic Heart Diseases
Kakkar A. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Kakkar V. V. - Heparin neutralising agents instigate the binding of heparin to live cells
Kakkar V. - Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Kakkar A. K. - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with nonmetastatic malignancy and venous thromboembolism (VTE)
  - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
Kaku S. - Anti-thrombotic effect of YM337 on carotid artery thrombi induced in squirrel monkeys by electrical stimulation
Kakusaka M. - Anti-platelet and anti-thrombotic effects of CS-747, a novel P2Y12 receptor antagonist, in combination with aspirin
Kalabova D. - Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe haemophilia A in the Czech Republic
Kalashnikova L. - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Kaldus T. - High prevalence of aspirin resistance in patients with a history of myocardial infarction
Kaldus T. - Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Kälebo P. - Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Kalina U. - Effect of antithrombin on lipopolysaccharide stimulated gene expression by human umbilical vein endothelial cells
Kallas A. - Inhibition of FVIII coagulation activity by FVIII-light-chain-specific antibodies of haemophilia A patient
Kalmar K. - Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
Kalokiri R. - Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
Kalokyri E. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Kalra N. K. - D-dimer for the exclusion of acute deep venous thrombosis and pulmonary embolism: a systematic review
  - Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
Kamada H. - C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
  - Decreased expression of protein C inhibitor in renal cell carcinoma cells is partly caused by DNA methylation
Kamath S. - Platelet activation and morphologic changes in hypertension
  - Platelet P-selectin and target organ damage in hypertension
Kamble P. - Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Kamei M. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Kamei S. - Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis
Kamiguti A. S. - Characterization of novel platelet and procoagulant activities from Bothrops cotiara snake venom
Kamikubo Y. - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
Kamikubo Y. - Oxidation products of common phospholipid specifically impair the activity and the reactivity of tissue factor pathway inhibitor
Kaminaka K. - Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
Kamiya T. - Abnormal subcellular localization of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) is associated with MYH9 mutations in patients with autosomal dominant macrothrombocytopenia with leukocyte inclusions
Kamphuisen P. W. - Thrombophilia strikes at all ages
  - Effectiveness of excluding pulmonary embolism in the elderly by using a clinical decision rule and d-dimer
Kamphuisen P. W. - Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism
Kanaji T. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
Kanaji S. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
Kanaji T. - Increased shear rate threshold in mouse blood for the dependence of platelet thrombus formation on glycoprotein Iba
Kanaji S. - Repression of integrin a1 gene (ITGA1) expression in human megakaryocytes coincides with DNA methylation of the core promoter
  - Convulxin binds to native, human glycoprotein Iba (GPIba)
Kanaji T. - Convulxin binds to native, human glycoprotein Iba (GPIba)
  - Regulation of megakaryocyte polyploidization and platelet release by the cytoplasmic tail of glycoprotein Iba
Kandidaki E. - Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
  - Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
Kane W. H. - Trp2063 and Trp2064 in the factor V C2 domain are required for factor Va binding to phospholipid membranes but not for assembly of the prothrombinase complex
  - A phosphatidylserine binding site distinct from the C2 domain membrane attachment site regulates the assembly and activity of the human prothrombinase
  - Tyr1956 and Leu1957 in the factor V C1-domain are required for high affinity binding of factor Va to phospholipid membranes
  - Identification of the multimerin binding region within the C2 domain of human factor V using constructs generated by alanine scanning and site-directed mutagenesis
Kaneda M. - Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
  - Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
Kanehara H. - Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family
Kaneider N. C. - Eosinophils as a novel target for protein C
  - Expression of endothelial protein C receptor by human neutrophils and its role in cell migration
Kaneko M. - Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
Kaneko M. - Mechanisms of platelet retention in the collagen-coated bead columns
Kanellopoulou G. - Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
Kanemoto K. - EF6265: a new synthetic, potent and selective plasma CPB/TAFIa inhibitor
Kang H. J. - Thrombin-activatable fibrinolysis inhibitor is not associated with the occurrence of ischemic stroke
Kang H. N. - A collaborative study to establish a Korean standard for factor VIII : C concentrate
  - A collaborative study to establish a Korea National Biological Standard for antithrombin III concentrate
Kang H. - Pharmacokinetics and pharmacodynamics of LB30870, a novel oral low molecular weight direct thrombin inhibitor in healthy volunteers
Kanki K. - A new global thrombosis test (GTT) shows impaired spontaneous thrombolytic activity in elderly and in habitual smokers
Kannemeier C. - An intracellular cofactor of Factor VII activating protease (FSAP) functions as an initiator of blood coagulation
  - Factor VII activating protease is an inhibitor of platelet derived growth factor-BB-mediated migratory and mitogenic activities on vascular cells
Kanse S. - Factor VII activating protease is an inhibitor of platelet derived growth factor-BB-mediated migratory and mitogenic activities on vascular cells
Kantidaki E. - Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
Kaplan R. C. - Factor VII levels, coronary artery disease, and MI
Kappelmayer J. - A novel mutation (1668delC) in the glycoprotein IIb (CD41) gene causing Glanzmann's thrombasthenia
Kappers-Klunne M. C. - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
  - Use of double virus-inactivated factor VIII concentrate (Immunate®) as treatment of von Willebrand disease
Kapsimalis Z. - Thrombosis in Neonates and children at various sites (1999–2002): thrombophilic factors, recurrence and outcome
Kaptein A. A. - Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
Kapustin S. I. - The prevalence of polymorphism PlA2 of platelet glycoprotein IIb-IIIa in the population of North-west Russia
Kapustin S. I. - Different risk of pulmonary embolism development in patients with deep-vein thrombosis from North-Western Russia having either factor V Leiden or prothrombin G20210A mutation
Kapustin S. I. - Venous thromboembolism in North-western Russia and genetic polymorphisms
  - Interaction between prothrombotic polymorphisms and lupus anticoagulant in chronic cerebrovascular disease
Karabinos I. - C-reactive protein: a link between inflammation and thrombosis formation in patients with unstable angina?
Karafoulidou A. - A case of an acquired inhibitor of Factor XIII
  - Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
  - Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
Karakas Z. - A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Karali V. - Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
Karamimagham T. - Coagulation disorders in b-thalassemic patients in Southern Iran
Karanth M. - Platelet, coagulation and endothelial markers in primary thrombocythaemia
Karas G. K. - Reproducibility of anticoagulation therapy control tested on fresh and frozen plasma
Karayeva N. - Anticoagulant effects of marinorm in coronary artery disease patients with hyperlipidemia
Karhunen P. J. - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
  - Kozak sequence polymorphism of the platelet glycoprotein Ibalpha gene and Thr789Ala polymorphism of the von Willebrand factor gene in fatal CAD
Karimi M. - Inherited coagulation disorders in southern Iran
  - Coagulation disorders in b-thalassemic patients in Southern Iran
Karimi M. - Identification of factor IX mutations in 17 Iranian families with hemophilia B
  - Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families
Karimi M. - Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 von Willebrand factor cleaving protease)
Karimi M. - The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Karimipour M. - Reporting presence of 9 novel mutations in hemophilia B patients in Iran
  - Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families
Kario K. - Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
Karlea A. - Hemophilia as a model for analysis of human germ-line mutagenesis: frequent mosacism and low male to female sex ratio for G:C®A:T nonCpG transitions and the first observation of a nucleotide bi-mutation are consistent with effects in early embryogenesis
Karlsson L. - Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
Karnicki K. - Risk of recurrence of cerebral venous and sinus thrombosis, influence of treatment
  - Cerebral venous sinus thrombosis. The spectrum of risk associated with this unique thrombotic disorder
Karnicki K. - Occurrence and management of abciximab induced pseudothrombocytopenia
Karovitch A. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Kárpáti L. - Plasma factor XIII activity, concentration and FXIII-A Val34Leu polymorphism in patients with myocardial infarction and/or coronary sclerosis
Karpinski G. - Activity of endogenous fibrinolytic system induced by exercise ECG test in patients with previous positive ECG-exercise test but without essential atherosclerotic changes in coronaries during angiography
Kasanuki H. - HLA-DR and CD40 ligand expressing T-lymphocytes are increased in circulation in patients with idiopathic dilated cardiomyopathy
  - Lower activation of circulating platelets after implantation of Toyobo LVAS was associated with lower incidence of thromboembolism: a comparison with Novacor LVAS
  - Insulin enhances human monocyte tissue factor expression induced by activated platelets via phosphatidylinositol-3-kinase signaling pathway
  - The functional profiles of circulating T lymphocytes distinguishes patients with stable angina and unstable angina
Kasapoglu A. - The relation of activated protein C resistance with ABO blood groups
Kashiwagi H. - Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
  - Interaction of CD47 with SHPS-1 negatively regulates platelet function
Kashiwagi H. - Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
Kasper R. S. - Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
  - Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Kasprzak A. - Thrombin activable fibrinolysis inhibitior (TAFI) in patients with obesity
Kassai B. - A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Kassis J. - Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
  - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
  - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
  - Haematologic factors potentially implicated in the pathophysiology of avascular necrosis of the femoral head (AVN): hypercoagulability as a cause of AVN
Kasuda S. - The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
Kasuda S. - M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Kasuga N. - Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Katayama Y. - Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
  - Correlation between anti-coagulant therapeutic range and Prothrombin Fragment 1 + 2 in Japanese patients with Cardioembolic Stroke
Katelani M. - Genetic risk factors in patients with myocardial infarction and correlation with echocardiographic study
Kato K. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
Kato H. - Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
Kato H. - Interaction of CD47 with SHPS-1 negatively regulates platelet function
Kato H. - Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
Katodritou E. - Thrombophilia and pregnancy
Katona B.G. - Rates of recurrent thromboembolism and bleeding in venous thromboembolism patients treated with long-term LMWH
Katona É. - Plasma factor XIII activity, concentration and FXIII-A Val34Leu polymorphism in patients with myocardial infarction and/or coronary sclerosis
Katopodis A. - Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
Katsadze Y. I. L. - Genetic features of thrombophilia in pediatric patients with migraine
Katsadze Y. I. L. - The test trombin for the whole blood (TTWB) is control of fibrinogen level for management of bleeding patient
Katsarou O. - Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
  - Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
  - A case of an acquired inhibitor of Factor XIII
Katsume T. - Usefulness of the prothrombin level measured by the carinactivase-1 method as the parameter of the coagulation activity during chronic warfarin therapy
Katsumi N. - ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Kaufhold A. - Improving efficacy of gene therapy of hemophilia B by the use of mutant FIX variants
Kaufman R. J. - The mutation Ser2117Leu, in the second hydrophobic spike of the factor V C2 domain, increases phospholipid affinity and specific activity
Kaufman R. - Biosynthesis and secretion of coagulation factor VIII
Kaufman R. J. - Genetic modifications that increase factor VIII secretion in vitro and in vivo
  - MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
Kaufmann R. - P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Kauke T. - A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Kauser K. - Overexpression of PAI-1 prevents abdominal aortic aneurysm development
Kaushansky K. - Thrombopoeitin: a tool to understand thromobopoiesis
Kavakli K. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Kavanagh B. - Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
Kaveri S. V. - Perturbations in the blood T-cell repertoire of inhibitor-positive patients with severe hemophilia A
  - Kinetics of hydrolysis by anti-FVIII antibodies in hemophilia A
  - Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
Kawaguchi C. - Activated factor VII enhances whole blood fibrinolysis due to urokinase-type plasminogen activator
Kawahara T. - Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Kawahara K. - Endothelial anticoagulant thrombomodulin (TM) as a natural anti-inflammatory, ‘HMG1 blocker’, inhibits pro-inflammatory cell activation
  - Activated protein C as a proteolytically activable antioxidant, anticoagulant protein
Kawahara K. - 2-Arachidonoylglycerol (2-AG) endocannabinoids, induces platelets conjugation with neutrophils (Platelet Satellitism) in vitro
Kawahara K. - The natural anticoagulant Thrombomodulin has radical scavenging activity and acts as an antioxidant C-type lectin
Kawaja M. - An evaluation of existing measurement methods in assessing menstrual blood loss in women with hereditary bleeding disorders
Kawamoto T. - Clinical significance of endothelial hemostatic markers in patients with ischemic heart disease
Kawana M. - HLA-DR and CD40 ligand expressing T-lymphocytes are increased in circulation in patients with idiopathic dilated cardiomyopathy
  - The functional profiles of circulating T lymphocytes distinguishes patients with stable angina and unstable angina
  - Lower activation of circulating platelets after implantation of Toyobo LVAS was associated with lower incidence of thromboembolism: a comparison with Novacor LVAS
  - Insulin enhances human monocyte tissue factor expression induced by activated platelets via phosphatidylinositol-3-kinase signaling pathway
Kawarabayashi T. - Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Kawashima Y. - Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
  - Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
Kawata T. - Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Kawecka I. - Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Kay M. A. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Kaye R. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Kazatchkine M. D. - Perturbations in the blood T-cell repertoire of inhibitor-positive patients with severe hemophilia A
  - Kinetics of hydrolysis by anti-FVIII antibodies in hemophilia A
Kazazian H. H. - Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Kazi M. - Influence of intraluminal thrombus on cellular and structural features of the aneurysm wall
Kazmierczak M. - Antiphospholipid antibodies in patients diagnosed for thrombophilia
Kazmierska E. - Estimation of plasminogen activator inhibitor type 1 (PAI-1) and plasmin-alpha-2-antiplasmin complex (PAP) serum activities in personal computers operators
Kearney E. M. - Plasma fibrinogen, factor IIXa and other coronary heart disease risk factors in exercising and nonexercising men aged 30–45 years
Kearon C. - Use of different d-dimer levels to exclude venous thromboembolism depending on clinical pretest probability
Kearon C. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Kearon C. - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
  - A systematic review of venous thromboembolism and long distance travel: strength of association and evidence for prevention
Kearon C. - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Kearon C. - Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study
  - A dose–response study of a recombinant human soluble thrombomodulin (ART-123) for prevention of venous thromboembolism after unilateral total hip replacement
  - Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
Kedees M. H. - Phosphorylation and expression of the extracellular domain of the platelet adhesion receptor, F11R (a.k.a. junctional adhesion molecule, JAM-1)
  - The platelet adhesion receptor, F11R (a.k.a. JAM-1), is critical for the initiation of plaque formation, thrombosis and atherosclerosis
Keeling D. - ‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
Keeling D. M. - The development of an automated, real time, oral anticoagulant dosing module to enhance traditional computerized decision support software (CDSS)
Keeling D. - Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Keeling D. M. - The PFA-100®: a screening tool for platelet dysfunction – the Oxford experience
Keenan R. - Sibling stem cell transplant to cure Bernard Soulier Syndrome
Keeney S. - Automated DNA sequencing of the essential regions of the FVIII gene for rapid carrier and prenatal diagnosis in hemophilia A
  - Removing the bottleneck – automated detection of point mutations in the factor VIII gene by fluorescent sequence trace subtraction following high-throughput DNA sequencing
Keeney S. - Type 2M von Willebrand disease: correlation of phenotype with genotype?
Kehoe J. - Effect of short-term, low-fat vegetarian diet and walking program on coagulation
Kehrel B. E. - Labrirhagin, a protein with metalloprotease and disintegrin domains from Trimeresurus albolabris venom, activates platelets by a mechanism involving GPVI, aIIbbIII3
  - Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Keijzer M. B. A. J. - Influence of vitamin supplementation on homocysteine and cysteine concentrations in blood
Keijzer H. J. - Is isolated postmethionine-load hyperhomocysteinemia a separate risk factor for venous thrombosis?
Keijzer M. B. A. J. - Elevated plasma cysteine concentration as a risk factor for venous thrombosis
Keil B. - Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
Keith J. C. - Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Kekomäki R. - Development of hemostasis in the very low birth weight premature infants
Keller J. - Unexpected pattern of hypercoagulable states in patients with patent foramen ovale (PFO) or atrial septal defect (ASD) and neurological events
Keller T. T. - Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Kellermann E. - Stability of rFVIII-FS after continuous infusion using a mini-pump infusion device
Kelley B. D. - Application of a novel polypeptide affinity ligand for purification of recombinant FVIII
Kelley R. F. - Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity
Kelley P. B. - Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Kelly J. A. - Recognized and unrecognized clinical venous thromboembolism (VTE) after acute ischemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
Kelly P. J. - Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Kelly J. A. - Performance characteristics of the VIDAS and IL test d-dimer (d-d) assays as exclusionary tests for venous thromboembolism (VTE) after acute ischemic stroke (AIS)
  - The relationship between plasma D-dimers (D-d) and thrombus load in patients with deep vein thrombosis (DVT) after acute ischaemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
  - The relationship between acute ischemic stroke (AIS) per se and plasma D-D (D-D) levels
Kelly M. J. - Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
Kelton D. - Multimerin supports platelet adhesion by functioning as an RGD ligand for platelet integrin receptors
Kelton J. - An overview on HIT
Kelton J. - The predictors of clinical outcome in patients with heparin-induced thombocytopenia
  - A systematic analysis of the effects of a thrombin-specific inhibitor, argatroban in HIT
Kemball-Cook G. - Expression of human tissue factor pathway inhibitor and hirudin fusion proteins on mouse vascular smooth muscle cells inhibits vascular remodeling after wire-induced carotid artery injury
  - Targeted expression of tissue factor pathway inhibitor and hirudin fusion proteins to endothelial cells reduces pathology in murine LPS-induced endotoxic shock – a novel model to study vascular inflammation
  - Two novel mutations in severe factor VII deficiency
Kemme M. J. B. - A novel method to accurately measure collagen/serotonin-induced platelet aggregation by whole blood impedance aggregometry in humans
Kempfer A. C. - Characterization of the von Willebrand factor present in circulating PMN
  - Comparative study of conformation sensitive gel electrophoresis and DNA sequencing for polymorphisms and mutation detection in von Willebrand disease type 2 N
Kempfer A. - Control of von Willebrand factor multimer size by a fibronectin related substance
Kempfer A. C. - Von Willebrand factor cleaving protease (VWFCP) activity in patients with pre-eclampsia history: preliminary results
  - Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
Kempton C. L. - Calcium ionophore A23187 and convulxin increase Xa generation in a cell-based model of hemostasis
  - Platelet P2Y12 inhibition decreases GPVI stimulated increases in thrombin generation on activated platelets
Kenche V. - Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
Kenet G. - Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
  - The molecular basis of Glanzmann thrombasthenia in Arabs
Kenet G. - Thrombophilia does not increase the risk for neonatal complications in preterm infants
Kenis H. - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
Kennedy G. - Increased neutrophil apoptosis in chronic fatigue syndrome
  - Increased plasma isoprostanes and other markers of oxidative stress in chronic fatigue syndrome
  - Dark chocolate inhibits platelet aggregation in healthy volunteers
  - Soluble P-selectin and P-selectin expression (CD62P) both reflect the same in vivo platelet activation
Kennelly B. M. - Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
  - Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Kenny D. - Shear-induced activation of metastatic cells is enhanced by the platelet secreteome and inhibited by aspirin
Kenworthy L. - ‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
Keown M. - European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
  - European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
Keown M. - European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
Kerautret G. - Aspirine resistance: a particularly high prevalence in patients after ventricular assist device implantation
Kerbiriou-Nabias D. - The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
  - A new evidence of a relationship between store-operated calcium entry and the regulation of procoagulant phosphatidylserine exposure at the surface of stimulated cells
  - The role of the ATP-Binding Cassette transporter A1 (ABCA1) in phosphatidylserine cell surface exposure and in the modulation of the procoagulant phenotype
Kereiakes D. J. - Plasma procarboxypeptidase U is up-regulated in patients undergoing percutaneous intervention: effects of anticoagulant dosage of low molecular weight heparins
  - Elevated soluble thrombomodulin levels in patients with acute coronary syndrome: down-regulation by anticoagulant dosage of low molecular weight heparins
  - Rapid point-of-care assessment of enoxaparin activity during percutaneous coronary interventions: the ELECT study
Kerényi A. - A novel mutation (1668delC) in the glycoprotein IIb (CD41) gene causing Glanzmann's thrombasthenia
Kerényi A. - Factor XIII subunit B: a protein A binding protein
Kerlin B. - Altered vascular remodeling in hyperfibrinogenemic mice
Kerschbaum G. - Thrombin generation in patients with stroke and elevated factor VIII levels
Kerschbaumer R. - Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
Kershaw G. - The control of von Willebrand Factor multimer size by thrombospondin-1
Kershaw G. - Screening for the Factor V Leiden mutation with a Russell's viper venom-based clotting test
Keshta S. - Ultrastructural changes in platelets after surgical manipulations in pigs liver
Kessler T. - Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Kessler M.-E. - No influence of alcohol intake on the pharmacokinetics or pharmacodynamics of the oral direct thrombin inhibitor, ximelagatran, in healthy volunteers
Kessler C. - Management of refractory postoperative cardiac bleeding with recombinant Factor VIIa (rFVIIa): Cases reported to the hemostasis.com registry
Kessler C. - Bleeding due to platelet disorders - and treatment: Review of current and future anticoagulants and their potential reversal by rFVlla
Kessler C. M. - Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
Kett D. - Successful outcome of rituximab therapy for spontaneous refractory high titer FVIII inhibitors
Kettenis I. M. J. - Prescribing anticoagulant prophylaxis in patients with hematological or solid tumor malignancies and central vein catheters: a nationwide survey
Keuren J. - Specific interaction of the proteolytic SPII fragment of von Willebrand factor with fibrin
Keuren J. - Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
Key N. - Stored platelets contain residual amounts of tissue factor
Key N. S. - Intrasvascular tissue factor procoagulant activity increases following joint replacement surgery
  - Tissue factor in sickle cell disease: Source and potential mediators
Key N.S. - Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Key N. - Successful liver transplantation in a hemophilia A patient with high titer factor VIII inhibitor
Khachidze M. - Functional resequencing of the factor IX (f-IX) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-IX activity levels in the GAIT project
Khachidze M. - Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
Khachigian L. M. - Protein–protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA-binding
Khachigian L. - DNAzymes targeting immediate-early genes: potential therapeutic tools in in-stent restenosis and angiogenesis
Khair K. - Subcutaneous administration of protein C
  - Transient lupus anti-coagulant directed against factor II
  - The mechanism of platelet activation by recombinant factor VIIa in normal subjects and inherited hemostatic disorders – a whole blood, flow cytometric study
Khalil R. - Plasminogen activators, plasminogen activator inhibitor-1 and D-dimer levels in gynecological cancer
Khalil F. - Relationship of thromboembolism (TE) to subsequent cancer diagnosis: a study in a veteran population
Khalil I. - High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon
Khamaysi I. - Endothelial protein C receptor (EPCR) is expressed in placental villi and cultured syncytiotrophoblasts
Khan A. - Thromboprophylaxis in medical patients: national survey of consultant physicians in the United Kingdom
  - Fatal pulmonary embolism in medical patients
Khanin M. A. - Role of protein C system in the advancement of activation zone of coagulation: A two-dimensional mathematical model
Khanin M. - Dynamics of the extracellular matrix degradation with the participation of urokinase-plasmin system: a mathematical model
Khanin M. A. - Loss of stability of the baseline state and the coagulation triggering: a mathematical modeling study
Khanin M. - Optimization model for type IV collagen degradation: determination of kinetic constants
Khanin M. - Thrombin generation in clotting factor deficiency: mathematical model
  - Coagulation activation in factors VIII and IX deficiency: a mathematical model
Khanin M. A. - Kinetics of factor XI activation by thrombin in the presence of activated platelets: a mathematical model, based on the Botts and Morales mechanism
Khare R. - Home-automated telemanagement affects quality of life in patients on anti-coagulation therapy
Khin T. - Qualitative Bernard Soulier syndrome: characterization of a normally expressed but functionally abnormal GPIb alpha
Khlevchuk T. - Advantage of the ‘Quick’ thrombolysis by streptokinase (SK)
Khodaiji S. - Local and clinical factors are the likely cause of venous thrombosis in lower limb arthroplasty
Khorana A. - Safety and tolerability of argatroban anticoagulation in patients with end-stage renal disease undergoing hemodialysis: a prospective study
Khorana A. - Molecular weight dependent heparin inhibition of endothelial cell stimulation by FGF-2 and VEGF
Khwaja H.A. - Haplotype and tissue-specific control of interleukin-6 expression and the implications in athero-thrombotic disease
Kiatchoosakun S. - Detection of the factor XIIIA Val34Leu polymorphism in Thais
Kibirev V. K. - Synthesis of arginine-containing peptides and study on their effects upon thrombin
Kido H. - Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis
Kidokoro A. - Prediction of the organ dysfunctions by coagulation/fibrinolysis molecular markers at the beginning of sepsis
Kieffer N. - Recombinant proteins mimicking an integrin a2b1 cytoplasmic tail heterodimer
  - Interacting sites within Talin and the integrin b3 cytoplasmic tail
  - Involvement of the aIIb subunit in postligand binding signaling events
Kieft G. J. K. - The role of spiral CT in alternative diagnosis in patients with clinical suspicion of pulmonary embolism
Kienast J. - Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Kiilerich S. - Randomized trial of tinzaparin, a low molecular weight heparin (LMWH) vs. placebo in the treatment of mild-to-moderately active ulcerative colitis
Kilinc Y. - Erythrocytic membrane proteins in sickle cell anemia in crisis and steady state
Kim J. - Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by NQ12, a novel antithrombotic agent
Kim S. - Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by NQ12, a novel antithrombotic agent
Kim G. H. - Detection of Ala601-Thr mutation in dysplasminogenemic patients with thrombosis in Korean population
Kim B. K. - A common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its association with a haplotype in the Korean population
Kim S. O. - A common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its association with a haplotype in the Korean population
Kim S. W. - Trp2063 and Trp2064 in the factor V C2 domain are required for factor Va binding to phospholipid membranes but not for assembly of the prothrombinase complex
Kim N. K. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim H. S. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim H. C. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim C. S. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim I. H. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim S. H. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Kim S. - Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, C17 and C270
Kim K. H. - Characterization of mutations of the factor VIII gene in Korean hemophilia A patients
Kim I. J. - Characterization of mutations of the factor VIII gene in Korean hemophilia A patients
Kim C. M. - Characterization of mutations of the factor VIII gene in Korean hemophilia A patients
Kim E. - Binding of heparin to alkaline earth and transition metals
Kim A. - Pharmacokinetics and pharmacodynamics of LB30870, a novel oral low molecular weight direct thrombin inhibitor in healthy volunteers
Kim J. - Pharmacokinetics and pharmacodynamics of LB30870, a novel oral low molecular weight direct thrombin inhibitor in healthy volunteers
Kim S. - Characterization of protein Kinase B/Akt activation and its role in thrombin and thrombin receptor-activating peptide-induced platelet activation
Kim S. N. - A collaborative study to establish a Korea National Biological Standard for antithrombin III concentrate
Kim J. M. - A collaborative study to establish a Korean standard for factor VIII : C concentrate
Kim S. N. - A collaborative study to establish a Korean standard for factor VIII : C concentrate
Kimura T. - Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747, a novel P2Y12 receptor antagonist
Kinane D. - Oral infection as a risk factor of atherosclerosis: first results of an intervention study
King J. H. - Protein C levels in critically ill ICU patients: differences seen between patients with and without sepsis
Kingsland S. - Purification and formulation of a dual viral-inactivated fibrinogen concentrate for use in a fibrin sealant
Kini R. M. - The catalytic subunit of pseutarin C, a group C prothrombin activator from Pseudonaja textilis is structurally similar to blood coagulation factor X
  - Comparative molecular modeling of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the venom of eastern brown snake
  - cDNA sequence of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the eastern brown snake (Pseudonaja textilis): its structural similarity to blood coagulation factor V
Kinlaw L. M. - Diet-induced hyperhomocysteinemia leads to a dysfibrinogenemia, elevated levels of plasminogen activator inhibitor-1 (PAI-1) and delayed clot lysis
Kinning E. - Compound heterozygous Protein C deficiency resulting in neonatal purpura fulminans: identification of a novel mutation and its functional consequences
Kinnon K. - Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Kinsman R. - Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
Kinzl L. - PTS after calf vein thrombosis (CVT): a 10-year follow-up
Kioumi A. - Thrombophilia and pregnancy
Kirby A. - Heparin-induced thrombocytopenia (HIT) in neonates and very young children undergoing congenital cardiac surgery: a likely under-recognized complication with significant morbidity and mortality: report of 4 sequential cases
  - Report of argatroban infusions for heparin-induced thrombocytopenia (HIT) diagnosed by functional assay in 2 congenital cardiac surgery patients, a neonate and a 5-month old
Kirchhofer D. - Differential use of variable domains of D3H44 antibody in binding to tissue factor or to an anti-idiotypic antibody
  - Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity
Kirchmaier C. M. - Using a modified thrombin generation assay for potency assessment of B-domain deleted recombinant factor VIII (ReFacto®)
  - Electron microscopy of thrombasthenic platelets after rFVIIa substitution
  - Thrombin generation in platelet-rich plasma (PRP) is enhanced in patients with metabolic syndrome
Kirchmaier C.-M. - Multicenter study of the DGTI: factor VIII determination of FVIII products with a chromogenic method®
Kirchmayr K. - The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
Kirkpatrick H. M. - Expression of recombinant human gla-domainless factor X (gdFX) in the baculovirus: assessing substrate recognition by the intrinsic tenase complex
Kirsch M. - Aspirine resistance: a particularly high prevalence in patients after ventricular assist device implantation
Kirschbaum N. - Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Kirwan C. - Increase in platelet VEGF release in early breast cancer
Kirwan C. - Anticoagulant prophylaxis usage in cancer patients undergoing treatment
Kiselyova Z. - Complex of Glycoprotein IIb/IIIa – von Willebrand factor (GP IIb/IIIa-vWF) in blood of patients with ischemic heart disease
Kisiel W. - Tissue factor and tissue factor pathway inhibitor expression by adherent monocytes and alveolar macrophages
Kiss C. - A novel mutation (1668delC) in the glycoprotein IIb (CD41) gene causing Glanzmann's thrombasthenia
Kister J. L. - A new method for identification of false-negative testing for lupus anticoagulant due to contamination of test plasma by platelet-derived micropatricles
Kistler J. P. - Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Kitajima I. - Imaging and characterization of the procoagulant activity appeared on the surface of platelet thrombi formed on the collagen surface under blood flow conditions
  - Intracellular behavior of anti-thrombin Morioka (Cys95Arg), a mutant protein causing type I deficiency: escape from intracellular protein degradation systems and accumulation within newly formed Russell's body-like structures
Kitchen S. - Transport of blood samples through a pneumatic tube system causes loss of platelet function
  - Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing program
  - Accuracy of laboratory diagnosis of familial thrombophilia, 2001–2002: UK NEQAS experience
Kitchen N. D. - Serial changes in hemostasis following subarachnoid hemorrhage
Kitchen S. - An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Kitchen D. - An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Kitchen D. P. - Artificially depleted plasmas are suitable for proficiency testing of INR determination with some POC devices
Kitchen S. - Artificially depleted plasmas are suitable for proficiency testing of INR determination with some POC devices
  - SSC classification of hemophilia A: is it achievable? A UKNEQAS supplementary exercise
  - Use of SSC/ISTH secondary standard to evaluate laboratory performance: A UK NEQAS for blood coagulation proficiency testing exercise
Kitchen D. P. - Use of SSC/ISTH secondary standard to evaluate laboratory performance: A UK NEQAS for blood coagulation proficiency testing exercise
Kitchen S. - A comparative study of new generation blood sampling tubes for thrombophilia investigations
  - Von Willebrand factor measurement in the UK NEQAS proficiency testing program
Kitchen D. - Von Willebrand factor measurement in the UK NEQAS proficiency testing program
Kitchen S. - Characterization of a new therapeutic recombinant human anti-thrombin concentrate
Kitchen D. P. - Possible causes of variation in INR results in UK NEQAS EQA program for Near Patient Testing/Point of Care devices
Kitchen S. - Possible causes of variation in INR results in UK NEQAS EQA program for Near Patient Testing/Point of Care devices
Kitchen S. - Results of d-dimer in the UK NEQAS (Blood Coagulation) proficiency testing program: Urgent need for improvements in Standardization of testing and reporting
Kitchen D. P. - Results of d-dimer in the UK NEQAS (Blood Coagulation) proficiency testing program: Urgent need for improvements in Standardization of testing and reporting
Kitchen S. - Diagnosis of factor XIII deficiency – room for improvement? Experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
Kitchen D. - Diagnosis of factor XIII deficiency – room for improvement? Experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
Kitchen S. - Marked variation in d-Dimer concentration as determined by four different assays
  - Isolated sustained elevated antib2 Glycoprotein 1 antibodies: association with primary anti-phospholipid syndrome and thrombotic events
  - ROTEG thromboelastography: sample stability and results in warfarinized and heparinized patients
  - The effect of two novel plastic citrate tubes (BD Vacutainer Plus): Results in normal subjects and subjects undergoing Unfractionated heparin therapy
Kitzis A. - Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
Kiyoi T. - Interaction of CD47 with SHPS-1 negatively regulates platelet function
  - Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
  - Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
Kjalke M. - Colocalization of recombinant human factor VIIa with its substrates on highly procoagulant COAT-platelets
Klaeffling C. - The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
Klamroth R. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Klarmann D. - Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
  - F VIII:C, Ristocetin-cofactor and von Willebrand factor in children with venous thrombosis or cerebral infarction
  - Long-term prophylaxis with FEIBA® in patients with high-responding inhibitors
  - Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
Kleesiek K. - Expression of wild type tissue factor pathway inhibitor (TFPI) and the first natural TFPI mutant ([P151L]) in insect and mammalian cells
  - The G allele of IL-6–174G/C polymorphism is a risk factor for restenosis after coronary stent implantation by increased inflammation and platelet activation
  - Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
  - Quantification of tissue factor pathway inhibitor (TFPI) in human seminal plasma and in human ovarian follicular fluid
Kleiman N. S. - Rapid point-of-care assessment of enoxaparin activity during percutaneous coronary interventions: the ELECT study
Klein L. - Temporal patterns and clinical outcomes in patients with heparin – induced thrombocytopenia
Klein O. - Temporal patterns and clinical outcomes in patients with heparin – induced thrombocytopenia
Klein A. - Safety and efficacy of using Low-Molecular-Weight Heparins to bridge patients on long-term warfarin
Klement P. - GH9001, a novel anti-thrombotic agent, is more effective than low-molecular-weight heparin, fondaparinux, or hirudin in rabbit models
Klement P. - Paradoxical effect of unfractionated heparin in combination with streptokinase on arterial recanalization
Klenner A. - Benefit and risk of heparin addition in maintaining peripheral venous catheters in neonates – a prospective, double-blind, placebo-controlled trial
Kleophas W. - Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Klerk C. P. W. - Malignancy and low-molecular weight-heparin therapy: the MALT trial
Klimenko O. - Nitric oxide, cytokine and hemostasis in stroke
Klimova N. - Red blood cells ABH and Lewis antigens prevalence in von Willebrand disease patients
Klimpel P. - Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
  - Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
Kling S. J. - Polymorphisms in the 5'UTR of the tissue factor (TF) gene are associated with differences in total and surface clotting activity and TF mRNA of endothelial cells
Klingbiel T. - Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
Klinge J. - Disseminated intravascular coagulation after varicella infection
Klinge J. - Thrombin generation in patients with stroke and elevated factor VIII levels
Klinge J. - Application of human factor XIII in children with massive pleural effusions after open heart surgery
Klingebiel T. - Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
  - F VIII:C, Ristocetin-cofactor and von Willebrand factor in children with venous thrombosis or cerebral infarction
  - A new protocol for inhibitor elimination in high responding hemophilia A patients
  - Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
Klinkhardt U. - Effects of argatroban in combination with oral anticoagulation on thrombin generation
Klocke A. - Microvesicle and platelet associated tissue factor promote initiation of coagulation
Klockgether T. - The risk of heparin-induced thrombocytopenia and the frequency of heparin-dependent antibodies in neurologic patients treated with unfractionated heparin
Kluft C. - Atorvastatin strongly reduces C-reactive protein, but shows less marked effect on other prognostic inflammatory markers
Kluft C. - The long-term analytical performance of assay of anti-thrombin, protein C and protein
  - Decrease of thrombophilia variables by aggressive vs. conventional atorvastatin treatment in patients with type 2 diabetes mellitus
Kluft C. - Relevance of interindividual variability in d-dimer composition for comparison of assays
Kluijtmans L. A. J. - Effect of the methionine synthase reductase A66G polymorphism on total homocysteine levels and venous thrombosis risk
  - Contribution of genetic factors to mild hyperhomocysteinemia
Kluin-Nelemans J. C. - The contribution of inherited thrombophilic risk factors to venous thromboembolism (VTE) in patients with systemic lupus erythematosus (SLE)
  - Arterial thromboembolism (ATE) in patients with systemic lupus erythematosus (SLE): the contribution of inherited thrombophilic risk factors
Klukowska A. - Hemorrhage into the right cerebella hemisphere in hemophiliac boy with factor VIII inhibitor
  - Immune tolerance induction in the treatment of children with haemophilia A complicated by factor VIII inhibitor
Knapik-Kordeck M. - Anti-oxidized LDL antibodies in patients with abdominal aorta aneurysm and arteriosclerosis obliterans
Knapik-Kordecka M. - Alpha 1-anti-trypsin concentration and atheromatosis risk factors in patients with abdominal aorta aneurysmata
Knapp-Clevenger R. - Successful antithrombotic therapy employing intravenous bolus low molecular weight heparin in an extremely preterm infant
  - Lipoprotein A contributes to genetic risk for Venous Thrombosis and Arterial Stroke in U.S. Children
  - Low-molecular-weight heparin dose requirements are age-related through childhood
  - Recombinant activated protein C (drotrecogin) is effective for purpura fulminans secondary to severe genetic protein C deficiency
Knight C. G. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
Knight S. - Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
  - Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
  - Effect of warfarin anticoagulants on elements of the tissue factor pathway and other procoagulant markers
Knight C. G. - The use of synthetic triple helical peptides to define a recognition motif in collagen III for human platelet receptor, Glycoprotein VI
  - Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
Knight S. - TAFI antigen levels in local hemophilia A and vWD population
Knitter G. - CTRP1 – a vascular wall protein that can prevent platelet thrombosis without causing bleeding
Knobe K. - Why does the mutation G 17736A, Val 107 Val (silent), in the FIX gene cause hemophilia B in five Swedish families?
Knöbl P. - Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin®)
  - Changes in ADAMTS13 (vWF cleaving protease) activity after induced acute release of von Willebrand factor
Knoefler R. - Sinus venous thrombosis in children – a multifactorial etiology
Knoefler R. - Correlation of parameters characterizing healthy newborns with cord blood concentration of thrombin activatable fibrinolysis inhibitor (TAFI)
Knöfler R. - Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
Knovich M. A. - A simplified assay for VWF cleaving protease (ADAMTS-13) activity and inhibitor in plasma
Ko Y. - Recombinant truncated tissue factor triggers coagulation in normal human plasma via the extrinsic pathway
Kobayashi H. - Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Kobayashi E. - Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
Kobayashi J. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Kobayashi T. - Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Kober J. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Kobsar A. - cGMP regulates thrombopoietin-induced CD34+ human stem cell proliferation and differentiation into megakaryocytes
  - Activated platelets induce migration, proliferation and gene expression in human vascular endothelial cells
  - Inhibition of platelet activation in congestive heart failure by selective aldosterone receptor antagonism and angiotensin-converting enzyme inhibition – role of platelet VASP phosphorylation
  - The molecular mechanisms of platelet activation by prolactin
Kobzar G. - Comparison of platelet aggregation in venous and arterial blood
Koch M. - Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Koch D. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Kochanek S. - Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
Kocher T. - Oral infection as a risk factor of atherosclerosis: first results of an intervention study
Kodama K. - Platelet GP VI can be new anti-platelet target for prevention of acute coronary syndrome
Koder S. - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
  - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Koehler-Vajta K. E. - 23 years experience with the pateurized factor VIII concentrate Beriate HS (Hemate HS) in pediatric patients and young adults
Koenderman L. - a4 integrins and P-selectin mediate rolling and initial attachment of platelet-monocyte complexes to activated endothelium under flow conditions
Rosing J. - Functional impairment of protein S in carriers of the prothrombin G20210A mutation
Koerber J. M. - Variability in antifactor Xa assay procedures
Koestenberger M. - Combined effects of eptifibatide and melagatran on thrombin generation and platelet aggregation inhibition
Kogan A. - False-positive reaction upon determination of d-dimer by ELISA
Kogushi M. - Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Koh S. C. L. - Plasminogen activators, plasminogen activator inhibitor-1 and D-dimer levels in gynecological cancer
Koh S. - Coagulation and fibrinolysis during the menstrual cycle and the effects of increased body mass index
Kohei O. - Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Köhl U. - A new protocol for inhibitor elimination in high responding hemophilia A patients
Kohler H. P. - Seven novel mutations leading to congenital coagulation factor XIII deficiency
Koide T. - M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Koide T. - Zinc chelation by histidine-rich glycoprotein is essential for its interaction with coagulation and fibrinolysis factors and its ability to enhance fibrinolysis
Koike T. - Sensitivity of semiquantitative lupus anticoagulant test for the diagnosis of antiphospholipid syndrome
Koike H. - A new gene structure of disintegrin family: a subunit of dimeric disintegrin has short coding region
Koike H. - Roles of autolytic loop-2 and at Asp554 of human prothrombin in the specificity of meizothrombin
Koike T. - Synthetic inhibitors of coagulation factor Xa suppress thrombin generation without affection on initial thrombin forming time
Koizumi T. - Effect of KFA-1982, a new orally active factor Xa inhibitor, in a rabbit venous thrombosis model
Kojima M. - Effect of KFA-1982, a new orally active factor Xa inhibitor, in a rabbit venous thrombosis model
Kojima T. - Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse
  - Abnormal subcellular localization of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) is associated with MYH9 mutations in patients with autosomal dominant macrothrombocytopenia with leukocyte inclusions
Kojima T. - Ryudocan (syndecan-4) deficiency increases susceptibility to LPS-induced shock in mice
Kok K. F. - Higher reticulated platelet counts and enhanced expression of P-selectin in patients with immune thrombocytopenic purpura compared to patients with myelodysplastic syndromes
Kokame K. - Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
  - Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
Kokame K. - D1596-R1668 of von Willebrand factor is a minimal region recognized as a specific substrate for ADAMTS-13
Kolacz E. - Thrombin activable fibrinolysis inhibitior (TAFI) in patients with obesity
  - The influence of Percutaneous Transluminal Coronary Angioplasty (PCTA) in patients with stable angina on the inflammation markers, lymphocyte activation and platelet-leukocyte aggregates in peripheral venous blood
  - Antiphospholipid antibodies in patients diagnosed for thrombophilia
  - High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
Kolaitis N. - Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
  - Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Kolb G. - Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Kolb A. M. - Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin layer chromatography
Kolbach D. N. - Local changes in coagulation and fibrinolysis in patients with a previous deep venous thrombosis
  - Definitions of the post–thrombotic syndrome: a comparison with invasive venous pressure measurement
Kolesnikova I. M. - New polymerization sites in the central and peripheral domains of human fibrin molecule
  - Utilization of monoclonal antibodies for the quantification of molecular markers of hemostasis
Kolkman J. A. - Role of factor IX surface loop 342–347 in factor VIII-mediated enhancement of catalytic activity
  - Molecular events involved in factor IXa stimulation by the factor VIII A2 domain
Kollár A. - Thrombin receptors on the cells of the blood–brain barrier
Koller B. - P2Y12 regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
  - Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
Komanasin N. - Detection of the factor XIIIA Val34Leu polymorphism in Thais
Komáromi I. - Thrombin-blood coagulation factor XIII interaction: in silico experiments
Komarov A. - The effect of clopidogrel on walking distance and hemostasis in patients with intermittent claudication
Komisarenko S. V. - Ischemia/reperfusion induces binding of circulated immunoglobulins to the blood vessels in vivo
Komisarenko S. - N-terminal disulfide knot of fibrin increases the accumulation of hyaluronic acid in the pericellular matrix of human umbilical vein endothelial cells
Komisarenko S. V. - Utilization of monoclonal antibodies for the quantification of molecular markers of hemostasis
  - New polymerization sites in the central and peripheral domains of human fibrin molecule
Komori K. K. - Recombinant sendai virus-mediated intramuscular gene transfer of FGF-2 restores collateral blood perfusion of chronically ischemic rabbit hind limb, and inhibits neointimal hyperplasia of autologous femoral vein grafts
Komrska V. - A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A
Komusin P. J. - Optimization of factor VIII clotting assays: evaluation of VWF content in FVIII-deficient plasma and effect of albumin in dilution buffer
Komwilaisak P. - The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome
Kondashevskaya M. - Observation on behavioral and hematological stress parameters tending to disappear after injections of unfractionary heparin
  - The central effects of fivefold injections of unfractionary heparin in small doses
Kondashevskaya M. V. - The central effects of fivefold injections of unfractionary heparin in small doses
Kondo K. - Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Konegen A. - Comparison of two methods to assess platelet activation during and after CABG
  - Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Kong M. - Distinct dose-dependent effects of plasmin and TPA on coagulation and haemorrhage
König H. - The thrombogenic agent in prothrombin complex concentrates (PCC): Identification of elevated levels of prothrombin as the major cause
Konje J. - Changes in thromboelastography in low-risk women in the puerperium
Konkle B. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Konstantoulas C. - Polymorphisms in the thrombomodulin gene as risk factors for myocardial infarction (HIFMECH study)
Konstantoulas C. - A thrombomodulin (TM) gene promoter variant (TM-33G > A) in type 2 diabetes
  - Soluble endothelial cell markers (sTM, sEPCR and sVWF) in type 2 diabetes
Koopman M.M.W. - Comparison of 2 d-dimer assays (MDA®d-dimer and Tina-quant®d-dimer) in patients with suspected recurrent deep venous thrombosis – an interim analysis
Koopman M. M. W. - The risk of pregnancy complications in women from families with thrombophilic defects
Koopman H. M. - The development and evaluation of a quality of life questionnaire for children with hemophilia
Koopman M. M. W. - Absolute risk of venous thromboembolism (VTE) associated with a single or combined thrombophilic disorder. Preliminary results of a family cohort study
  - Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
  - Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremities: survival, risk factors and post–thrombotis syndrome
  - High levels of coagulation factors IX or XI: risk factors for pulmonary embolism?
  - Impact of knowledge of a positive family history on the clinical presentation of hemophilia
  - Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Preliminary results of a family cohort study
  - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
  - Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism
  - Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
  - Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
Koopmann M. M. - Tissue factor (TF) and high-sensitivity CRP (HS-CRP) in patients with peripheral arterial disease (PAD) undergoing peripheral bypass surgery or angioplasty: a retrospective study
Koopmeiners L. - Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Kopanakis C. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Kopetzki E. - The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Kopleman P. J. - Associations of hemostatic variables with changes in anthropometric measures and metabolic variables in the morbidly obese
Kopp C. W. - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
  - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
Kopp C. W. - High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
Kopp F. - Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Koppensteiner R. - Tissue factor (TF) and high-sensitivity CRP (HS-CRP) in patients with peripheral arterial disease (PAD) undergoing peripheral bypass surgery or angioplasty: a retrospective study
Koptikova J. - Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer – is there a space for multivariate predictive modeling?
Kopylov K. G. - Results of clinical use of ‘NovoSeven’ in Russia
Kopylov K. G. - Comparative study of the effect of recombinant factor VIIa on clot growth and thrombin generation in normal and hemophilia A plasma in vitro
  - Home treatment of patients with hemophilia in Russia
Korantzis I. - Thrombophilia and pregnancy
Kornbrust A. M. - Treatment of thrombotic complications and prophylactic use of protein C concentrate in two homozygous protein C deficient patients during surgery
Kornecki E. - The platelet adhesion receptor, F11R (a.k.a. JAM-1), is critical for the initiation of plaque formation, thrombosis and atherosclerosis
Kornecki E. - Genomic structure, organization and promoter analysis of the human F11 receptor (F11R) (junctional adhesion molecule-1, JAM-1)
  - Phosphorylation and expression of the extracellular domain of the platelet adhesion receptor, F11R (a.k.a. junctional adhesion molecule, JAM-1)
Koropouli M. - Left adrenal hemorrhage with intravascular coagulation- case report
Korporaal J. A. - The effect of oxidized low-density lipoprotein on the activation of platelets
Korte W. - Age but not the presence of cancer predicts impairment of the protein C pathway in surgical patients
  - Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
  - Triglycerides show an immediate increase during anticoagulant therapy for DVT without increase in thrombin generation
Kortulewski T. - A study of gene expression profiles during megakaryocytopoiesis
Korzh I. - The influence of cyclooxygenase-2-selective nonsteroid anti-inflammatory drugs on bleeding complications in aspirin users
Korzh O. - The influence of cyclooxygenase-2-selective nonsteroid anti-inflammatory drugs on bleeding complications in aspirin users
Korzh O. - The role of molecular markers of the coagulation system in patients with acute myocardial infarction
  - Correlation between endothelial haemostatic markers in patients with coronary heart disease
Korzh I. - Correlation between endothelial haemostatic markers in patients with coronary heart disease
Korzh O. - Influence of nadroparin on homocysteine level in aspirin-treated patients
Korzh I. - Effect of etanercept on procoagulant activity and fibrinolysis in patients with rheumatoid arthritis
Korzh O. - Effect of etanercept on procoagulant activity and fibrinolysis in patients with rheumatoid arthritis
Kosch A. - Sinus venous thrombosis in children – a multifactorial etiology
Kosch A. - Factor XII-deficiency is a risk factor for ischaemic stroke but not for venous thrombosis in children
Koschinsky M. L. - Molecular dissection of the human TAFI promoter
  - Effect of polymorphisms in the human TAFI 5'-flanking region on TAFI promoter activity
  - Polymorphisms in the 3'-untranslated region of the TAFI mRNA modulate TAFI gene expression through control of mRNA stability
  - A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) assembly
Kosmidou M. - Congenital defect of inferior vena cava and thrombophilia Leiden
  - Treatment of DIC: the role of PC
Kostelansky M. S. - High resolution crystal structures of two variant fibrinogens suggest ‘B:b’ interactions are critical to normal polymerization
Koster T. - Risk factors for recurrent venous thrombosis: a prospective follow-up of the Leiden thrombophilia study (LETS)
Köstering H. - Sensitivity of platelet retention test Homburg (RTH) in drug monitoring and measuring vs. Willebrand factor–mediated platelet adhesiveness
Kostka H. - Correlation of parameters characterizing healthy newborns with cord blood concentration of thrombin activatable fibrinolysis inhibitor (TAFI)
Kosugi S. - Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
  - Interaction of CD47 with SHPS-1 negatively regulates platelet function
  - Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
Kotitschke R. - Multicenter study of the DGTI: factor VIII determination of FVIII products with a chromogenic method®
Kotsi P. - Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
Kotsi P. - Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
  - A case of an acquired inhibitor of Factor XIII
Kotsis A. - High frequency of factor V Leiden and prothrombin G20210A mutations in Greek hemophiliacs
Kottke-Marchant K. - Multiplex PCR Nanogen gene chip assay for thrombospondin mutations associated with acute coronary syndromes
Kottke-Marchant K. - Does cyclooxygenase-2 have a role in aspirin-dependent platelet function?
  - Rapid point-of-care assessment of enoxaparin activity during percutaneous coronary interventions: the ELECT study
  - Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
Kottke-Marchant K. - High prevalence of aspirin resistance in patients with a history of myocardial infarction
Kottke-Marchant K. - Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Kottmann T. - Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
  - The G allele of IL-6–174G/C polymorphism is a risk factor for restenosis after coronary stent implantation by increased inflammation and platelet activation
Kotulová D. - Is infection a risk factor of acute ischemic stroke?
Kotzé H. - Dose-dependent inhibition of thrombosis by melagatran in a nonhuman primate model
Kotzé H. - Experience of using FEIBA™ to attenuate the effects of anticoagulation on inhibition of thrombogenesis in primates
Kotzsch M. - Microvesicle and platelet associated tissue factor promote initiation of coagulation
Koudela K. - Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Kouides P. A. - Treatment and management of women with bleeding disorders and menorrhagia (WBDM) study: study design and characteristics of women enrolled
Koulouris S. - C-reactive protein: a link between inflammation and thrombosis formation in patients with unstable angina?
Koumbanis B. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Kouramba A. - Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
  - A case of an acquired inhibitor of Factor XIII
Kovac M. - The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Kovacova E. - Serum homocysteine in chronic liver diseases – risk factor for thrombosis or protection against thrombosis?
Kovacs M. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Kovacs M. - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Kovacs M. - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Kovacs I.B. - GTT: A comprehensive in vitro haemostasis test, assessing platelet function, coagulation and thrombolytic activity from a single native blood sample
Kovacs M. J. - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
Kovalenko T. - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Kovalenko T. F. - Inheritable thrombophilias in women with high risk of obstetric complications in the Moscow population
Kovalenko T. - Impairment of morphology and NO release in cultured endothelial cells from rabbit coronary vessels following total irradiation by external CO60
Kovalenko T. - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Kovalski V. - Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
Kovalsky V. - Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
Kowalska M. A. - Murine (m) aIIb out-competes human (h) aIIb for mouse b3 in a transgenic mouse model: Implications for integrin subunit interactions
  - A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Kowlaska M. A. - Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
Koyama T. - Degradation pathway of the naturally occurring mutants of protein C and plasmin inhibitor by the proteasome
  - An intracellular cofactor of Factor VII activating protease (FSAP) functions as an initiator of blood coagulation
Kozak M. - Comparison of magnetic resonance characteristics of the vessel wall between patients with classic and dilatative atherosclerosis
Kozanoglu H. H. - Erythrocytic membrane proteins in sickle cell anemia in crisis and steady state
Kozawa O. - Lack of a 2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
  - Lack of a2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
Kozian D. - The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Koziol J. - Platelet integrin a2 SNP 807C is a predictor of bleeding in Von Willebrand Disease (VWD) type 1
Koziolkiewicz W. - Phosphorylation of platelet proteins in hemodialysed patients is different than in control donors
Koziri A. - Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
  - Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
  - Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
  - Obesity and coagulation. Is there any correlation?
  - Left adrenal hemorrhage with intravascular coagulation- case report
Kozlova T. V. - The role of thrombophilias in the origin of cerebrovascular accidents at the patients with Atrial Fibrillation
Kozubski W. - High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
Kozyri A. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Kraaijenhagen R. A. - Optimal intensity of oral anti-coagulant therapy in patients with mechanical heart valves
  - Day-care or short-stay surgery and venous thromboemolism: an overview
Kraimps J. L. - Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
Krajewski J. - Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
  - A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
Kralisz U. - The role of integrin alpha2beta1 during activation of protein tyrosine kinases induced by low concentration of collagen
Kramer M. H. H. - Post-thrombotic complaints are not related to factor V Leiden mutation or elastic compression stockings: results of the MEGA Study
  - The assessment of pretest probability in patients with suspected Deep-Vein Thrombosis is of great value in nonacademic teaching hospitals
Kramer J. - Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Krandis A. - C-reactive protein: a link between inflammation and thrombosis formation in patients with unstable angina?
Kranenburg O. - Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Krasaesub S. - Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Krasnobrizha E. - Influence of streptokinase on the hemostasis system parameters
Kratochvilova H. - Serum homocysteine in chronic liver diseases – risk factor for thrombosis or protection against thrombosis?
Kraus D. - Tissue factor and tissue factor pathway inhibitor expression by adherent monocytes and alveolar macrophages
Krause M. - Important Role of FV G1691A and FII G20210A in women with pregnancy loss without apparent causes
  - Rituximab – a challenge for the therapy of inhibitors to factor VIII
Krause M. - Rituximab – a challenge for the therapy of inhibitors to factor VIII
Krause S. - Oral infection as a risk factor of atherosclerosis: first results of an intervention study
Krause M. - Mild ADAMTS-13 deficiency in patients with ischemic stroke
Krause M. - Association between factor XIII Val34Leu polymorphism and risk of ischemic stroke in young patients
Krause M. - ADAMTS-13 activity and corresponding inhibitor titers during plasma exchange therapy in 13 pts with Thrombotic Thromobcytopenic Purpura (TTP)
Krauze-Brzosko K. - Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Kravets V. N. - Xenogenic immunoglobulins can be used in treatment coagulation disorders
Kreß J. - Mechanisms involved in the differential regulation of endothelial cells and lung fibroblasts by the hyaluronan-binding protease
Kreß J. - Intracellular signaling in human endothelial cells induced by the hyaluronan-binding protease
Kredteck A. - The risk of heparin-induced thrombocytopenia and the frequency of heparin-dependent antibodies in neurologic patients treated with unfractionated heparin
Kreis S. - Interacting sites within Talin and the integrin b3 cytoplasmic tail
  - Recombinant proteins mimicking an integrin a2b1 cytoplasmic tail heterodimer
Kremer Hovinga J. - Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
Kremer Hovinga J. A. - Observations on immunoadsorption (IA) as an auxiliary therapy for acquired thrombotic thrombocytopenic purpura (TTP)
Kremer Hovinga J. - A functional single-nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) associated with risk and outcome of meningococcal disease (MD)
Kretschmer V. - Evaluation of an automated von Willebrand factor (vWF) antigen assay
  - Influence of time interval after sampling on variability of thrombelastography (TEG) results
Kreutzer G. O. - Anticoagulation therapy outcome in children after extracardiac conduit Fontan operation
Kreuz W. - Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
  - Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
Kreuz W. - A new protocol for inhibitor elimination in high responding hemophilia A patients
Kreuz W. - Long-term prophylaxis with FEIBA® in patients with high-responding inhibitors
  - The role of VWF in immune tolerance induction
  - F VIII:C, Ristocetin-cofactor and von Willebrand factor in children with venous thrombosis or cerebral infarction
  - Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
  - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Kreuzer C. - Hemostatic risk factors, metabolic control, and microalbuminuria in diabetes mellitus type 1
Krilis S. - New insights into mechanisms of antiphospholipid syndrome
Krinninger B. - The impact of interassay-variations in the International Normalized Ratio on dosing oral anti-coagulants
Krippl P. - Association of a common 936 C/T polymorphism in the gene of vascular endothelial growth factor and VEGF plasma levels
Krishna R. - Evaluation of the point of care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for assessment of platelet function inhibition by platelet GPIIb-IIIa antagonists
Krishnamurthy R. - Differential use of variable domains of D3H44 antibody in binding to tissue factor or to an anti-idiotypic antibody
Krishnaswamy S. - Equilibrium binding measurements of the exosite-dependent interactions of substrates or product with the prothrombinase complex
  - Competitive activation of IX and X by the extrinsic pathway. Studies of the differential regulation of enzyme and products by antithrombin III and tissue factor pathway inhibitor reveal that active IXa is a major reaction product of this pathway
Kristensen S. D. - The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
Kristensen A. T. - Hemostatic effect of rFVIIa (NovoSeven®) in a mouse model of type 1 von Willebrand disease (VWD)
Kristensen O. - Elevated concentrations of nitrate in plasma from smokers
  - Prevalence of hyperhomocysteinemia among aluminum industry workers
Kristensen A. T. - Hemostatic effect of three factor VIIa analogs in antibody-induced hemophilia A in mice
Kroenke G. - Oxidized phospholipids induce the human heme oxygenase-1 via CREB: a feedback mechanism in inflammatory disorders
Krohne K. - cGMP regulates thrombopoietin-induced CD34+ human stem cell proliferation and differentiation into megakaryocytes
Kroll H. - Cell lines expressing recombinant platelet membrane glycoprotein isoforms as tools for the characterization of antibodies against low frequency alloantigens in neonatal alloimmune thrombocytopenia
Kroll B. - The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
Kroll M. H. - Tyrosine kinases regulate the activation of phosphatidylinositol 3-kinase in platelets stimulated by the PAR1-activating peptide
Kroner C. - IRS-1 mediates platelet inhibition by insulin via the inhibitory G-protein Gi
Kroner P. A. - Type 2 M von Willebrand disease due to linked P1266Q and V1279I substitutions in the von Willebrand factor A1 domain
Kroon-Batenburg L. M. W. - Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Kropacheva E. - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Kropacheva E. - The effect of clopidogrel on walking distance and hemostasis in patients with intermittent claudication
Krötz F. - Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
  - A cytochrome P450 2C8/9-derived EDHF inhibits platelet adhesion to endothelial cells in vitro
Kruchinsky N. G. - Carbon disulfide and low-level ionizing irradiation: causes of hypercoagulable state, impair cell–cell communication and accelerated atherosclerosis
Krueger L. A. - GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Kruip M. J. H. A. - Diagnostic performances of two new d-dimer assays in the diagnostic work-up of patients with suspected pulmonary emboli
Kruip M. J. H. A. - Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism
Kruithof E. K. O. - Effect of simvastatin on the production of tissue-type plasminogen activator in endothelial cells
Kruithof E. - Effects of statins on adhesion molecules expression in endothelial cells
Kruithof E. K. O. - High-level transgene expression of lentivirus-transduced human endothelial cells
  - Effects of simvastatin on secretagogue-induced exocytosis from endothelial cells
Kruithof C. J. - A new computer algorithm for better dosage of oral anti-coagulants
Kruithof E. K. O. - Structural elements in tissue-type plasminogen activator contributing to its storage in primary endothelial cells
Kruithof E. K. O. - Aspirin inhibits VCAM-1 expression induced by antiphospholipid antibodies
Kruse M. J. - Why did rFVIIa have no effect in post delivery bleeding? – a case-report
Ktena M. - Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Ku D. H. - Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
  - Patients with adverse pregnancy outcome have lower levels of protein Z and protein S compared to patients with normal pregnancy outcome
Kubatiev A. A. - Interleukin 1b modulates platelet function
  - Platelet–neutrophil interaction in Chernobyl wreckers accident liquidators
Kubisz P. - Epidemiology of inherited thrombophilia in Slovakia
  - TAFI and diabetic nephropathy
Kuca P. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Kudrna J. C. - Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
  - Thrombosis prophylaxis following total hip replacement
Kudryk B. - Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Kuehnl P. - Monitoring platelet concentrates (PCs) during storage by functional and immunological tests
  - Transfusion of activated platelets: increase of platelet-leukocyte binding in vivo
Kufrin D. - A novel platelet-specific delivery system for fibrinolytic agents
  - A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Kuhle S. - Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
  - A pharmacokinetic study of tinzaparin in pediatric patients
Kuhle S. - A case series of 72 neonates with renal vein thrombosis: data from 1 to 800-No-Clots registry
Kuhle S. - Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
  - A dose-finding study of Tinzaparin in pediatric patients
Kuhlisch E. - Correlation of parameters characterizing healthy newborns with cord blood concentration of thrombin activatable fibrinolysis inhibitor (TAFI)
Kuijpers M. - Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
Kuijpers M. J. E. - Glycoprotein Ib and integrin a IIbb 3 contribute to GPVI-dependent vWF-collagen induced thrombus formation under flow
Kukhoreva T. A. - Inheritable thrombophilias in women with high risk of obstetric complications in the Moscow population
Kuliopulos A. - Pepducin-based intervention of platelet signaling and systemic platelet activation
Kulkarni S. - A novel role for cytosolic calcium in down-regulating integrin aIIbb3 activation and platelet adhesiveness
Kulkarni S. - Tissue factor in sickle cell disease: Source and potential mediators
  - Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
  - Role of the Type Ia PI 3-kinase p110beta isoform in integrin alpha(IIb)beta(3) bi-directional signaling
Kulkarni R. - Heart disease among males with hemophilia
Kulkarni S. - Signaling events underlying thrombus formation
Kulkarni B. - Diagnosis of neonatal alloimmune thrombocytopenic purpura (NAITP) by genotyping and human platelet antigen frequency in the Indian population
Kulkarni R. - Renal disease among persons with hemophilia
Kuller L. H. - C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
  - Intracellular adhesion molecule-1 is associated with cardiovascular disease in elderly men and women
Kulman B. - An interactive coagulation laboratory database benefiting the entire Hemophilia Center team
Kumar P. - Heparin-induced anti-platelet antibodies in very low birth-weight infants
Kumar N. - Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Kumar A. - Role of platelet-leukocyte–endothelium interactions in neointimal hyperplasia
Kumar H. - Determination of free sulfhydryls in human factor VIII
Kunapali P. - Characterization of protein Kinase B/Akt activation and its role in thrombin and thrombin receptor-activating peptide-induced platelet activation
Kunapuli S. P. - Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, C17 and C270
Kunapuli S. - Human platelets generate thromboxane A2 upon interaction with immobilized fibrinogen without a requirement for adherence in a Syk-dependent manner
Kunapuli S. P. - Stimulation of PAR-1 does not lead to G protein redistribution in human platelets
  - Plasmin-mediated activation of platelets occurs through interaction with PAR-4
  - Specificity and redundancy of G-protein pathways in agonist-induced alpha granule release in human platelets
  - Characterization of 5'-upstream region of human phospholipase C-beta2 gene in megakaryocytic cell line
Kundu S. - Identification of a Factor IX cleaving protease and efficient reduction in a high purity Factor IX manufacturing process
Kunicki T. J. - The laboratory evaluation of aspirin-resistance in normal, healthy subjects
  - Platelet integrin a2 SNP 807C is a predictor of bleeding in Von Willebrand Disease (VWD) type 1
Kunicki T. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
  - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Kunicki T. J. - Convulxin binds to native, human glycoprotein Iba (GPIba)
  - Repression of integrin a1 gene (ITGA1) expression in human megakaryocytes coincides with DNA methylation of the core promoter
Kunieda Y. - ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Kunishima S. - Abnormal subcellular localization of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) is associated with MYH9 mutations in patients with autosomal dominant macrothrombocytopenia with leukocyte inclusions
Kunka S. - A proposed ISTH revised classification for the anti-phospholipid syndrome
Kunz F. - Platelet glycoprotein mRNAs are expressed in megakaryocytes and platelet like cells and are regulated during differentiation
Kuo A. - A novel platelet-specific delivery system for fibrinolytic agents
Kuo C. - Quantitative transcript profiling and novel gene identification of vascular endothelial cell subtypes by serial analysis of gene expression (SAGE)
Kuo A. - Mapping the interaction between uPAR and high molecular weight kininogen
Kupferminc M. - Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
Kuppuswamy M. N. - Congenital factor VII deficiency and thrombosis. Description of a novel mutation
Kurachi S. - Mechanisms of homeostasis of blood coagulation factors
Kurachi K. - Mechanisms of homeostasis of blood coagulation factors
Kurachi K. - Functional pan-universality of the age-related regulatory elements ASE and AIE, and development of age dimension technology
Kurachi S. - Functional pan-universality of the age-related regulatory elements ASE and AIE, and development of age dimension technology
Kurata Y. - Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
  - Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
  - Interaction of CD47 with SHPS-1 negatively regulates platelet function
Kurinczuk J. - Changes in thromboelastography in low-risk women in the puerperium
Kurnik K. - Sinus venous thrombosis in children – a multifactorial etiology
  - Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
  - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
  - Factor XIII Val34Leu polymorphism in pediatric thrombophilia evaluation: is there clinical relevance?
  - Factor XII-deficiency is a risk factor for ischaemic stroke but not for venous thrombosis in children
  - Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
Kuro M. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Kuroda K. - Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
Kurosawa S. - Soluble endothelial cell markers (sTM, sEPCR and sVWF) in type 2 diabetes
Kurowski S. - Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Kurz X. - Patients with the post–thrombotic syndrome have worse disease severity and quality of life than patients with primary chronic venous disease
Kus J. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Kusama H. - Effect of KFA-1982, a new orally active factor Xa inhibitor, in a rabbit venous thrombosis model
Kushak R. I. - Shiga toxin with antecedent TNF-a induces enhanced tissue factor activity on human glomerular, but not on umbilical vein, endothelial cells
  - Globotriasylceramide (Gb3) and blood-borne tissue factor (TF) colocalize with platelets during platelet adhesion/aggregation onto a collagen-coated surface exposed to flowing blood
Kuskowski M. - Venous thromboembolism is common but does not alter survival in glioblastoma multiforme
Kuwahara M. - Mechanisms of homeostasis of blood coagulation factors
Kuzmin V. M. - Coagulation activation in factors VIII and IX deficiency: a mathematical model
Kuznetsova P. - Screening for asymptomatic deep vein thrombosis after major orthopedic surgery: findings of the Global Orthopaedic Registry (GLORY)
  - Duration of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: findings from the global orthopedic registry (GLORY)
Kuznik B. - Influence of hypophysectomy on hemostasis in chickens
  - Disseminated intravascular coagulation in surgary
Kwaceniak M. - Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Kwasny-Krochin B. - Suppression of thrombin generation and fibrinolysis in patients with rheumatoid arthritis treated with anti-TNFa monoclonal antibody (Infliximab)
Kwiecinski H. - Polymorphisms of the factor VII gene and ischemic stroke in young adults
Kwong L. - The financial burden of VTE: Arixtra a cost-saving option
Kyoung Rhan L. - Circulating vascular cell adhesion molecule-1 in patients with operable breast cancer
Kyrle P. A. - Treatment of patients with VWD requiring elective surgery with a pasteurized von Willebrand Factor/FVIII concentrate (Haemate®P) – the use of a PK-guided approach
  - The effect of pretreatment with clopidogrel on platelet and coagulation activation in patients with stable angina undergoing elective coronary stenting
  - The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
  - Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
Kyrle P. - Predicting the risk of recurrence of venous thromboembolism – genetic determinants and elevated coagulation factors
Kyung Soon S. - Circulating vascular cell adhesion molecule-1 in patients with operable breast cancer